[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.255.49. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
1.
Jarjoura  D, Polen  A, Baum  E, Kropp  D, Hetrick  S, Rutecki  G.  Effectiveness of screening and treatment for depression in ambulatory indigent patients.  J Gen Intern Med. 2004;19(1):78-84.PubMedGoogle ScholarCrossref
2.
Wells  KB, Sherbourne  C, Schoenbaum  M,  et al.  Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.  JAMA. 2000;283(2):212-220.PubMedGoogle ScholarCrossref
3.
Wells  K, Sherbourne  C, Schoenbaum  M,  et al.  Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial.  Arch Gen Psychiatry. 2004;61(4):378-386.PubMedGoogle ScholarCrossref
4.
Improving mental health and addressing mental illness. Community Preventive Services Task Force. http://www.thecommunityguide.org/mentalhealth/index.html. Accessed December 2, 2015.
5.
Witters  D, Liu  D, Agrawal  S. Depression costs US workplaces $23 billion in absenteeism. Gallup. http://www.gallup.com/poll/163619/depression-costs-workplaces-billion-absenteeism.aspx. Accessed July 14, 2015.
6.
O’Connor  E, Rossom  RC, Henninger  M,  et al.  Screening for Depression in Adults: An Updated Systematic Evidence Review for the US Preventive Services Task Force: Evidence Synthesis No. 128 [AHRQ Publication No. 14-05208-EF-1]. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
7.
Beck  CT, Gable  RK.  Comparative analysis of the performance of the Postpartum Depression Screening Scale with two other depression instruments.  Nurs Res. 2001;50(4):242-250.PubMedGoogle ScholarCrossref
8.
Tandon  SD, Cluxton-Keller  F, Leis  J, Le  HN, Perry  DF.  A comparison of three screening tools to identify perinatal depression among low-income African American women.  J Affect Disord. 2012;136(1-2):155-162.PubMedGoogle ScholarCrossref
9.
Williams  JW  Jr, Mulrow  CD, Kroenke  K,  et al.  Case-finding for depression in primary care: a randomized trial.  Am J Med. 1999;106(1):36-43.PubMedGoogle ScholarCrossref
10.
US Preventive Services Task Force.  Screening for depression in adults: US Preventive Services Task Force recommendation statement.  Ann Intern Med. 2009;151(11):784-792.PubMedGoogle ScholarCrossref
11.
Casacalenda  N, Perry  JC, Looper  K.  Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.  Am J Psychiatry. 2002;159(8):1354-1360.PubMedGoogle ScholarCrossref
12.
Pinquart  M, Duberstein  PR, Lyness  JM.  Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.  Am J Psychiatry. 2006;163(9):1493-1501.PubMedGoogle ScholarCrossref
13.
Wilson  K, Mottram  P, Sivanranthan  A, Nightingale  A.  Antidepressant versus placebo for depressed elderly.  Cochrane Database Syst Rev. 2001;(2):CD000561.PubMedGoogle Scholar
14.
Pinquart  M, Sörensen  S.  How effective are psychotherapeutic and other psychosocial interventions with older adults? a meta-analysis.  J Ment Health Aging. 2001;7(2):207-243.Google Scholar
15.
Leung  SS, Leung  C, Lam  TH,  et al.  Outcome of a postnatal depression screening programme using the Edinburgh Postnatal Depression Scale: a randomized controlled trial.  J Public Health (Oxf). 2011;33(2):292-301.PubMedGoogle ScholarCrossref
16.
Wickberg  B, Tjus  T, Hwang  P.  Using the EPDS in routine antenatal care in Sweden: a naturalistic study.  J Reprod Infant Psychol. 2005;23(1):33-41.Google ScholarCrossref
17.
Yawn  BP, Dietrich  AJ, Wollan  P,  et al; TRIPPD practices.  TRIPPD: a practice-based network effectiveness study of postpartum depression screening and management.  Ann Fam Med. 2012;10(4):320-329.PubMedGoogle ScholarCrossref
18.
Morrell  CJ, Slade  P, Warner  R,  et al.  Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care.  BMJ. 2009;338:a3045.PubMedGoogle ScholarCrossref
19.
Glavin  K, Smith  L, Sørum  R, Ellefsen  B.  Redesigned community postpartum care to prevent and treat postpartum depression in women: a one-year follow-up study.  J Clin Nurs. 2010;19(21-22):3051-3062.PubMedGoogle ScholarCrossref
20.
Kozinszky  Z, Dudas  RB, Devosa  I,  et al.  Can a brief antepartum preventive group intervention help reduce postpartum depressive symptomatology?  Psychother Psychosom. 2012;81(2):98-107.PubMedGoogle ScholarCrossref
21.
McGregor  M, Coghlan  M, Dennis  CL.  The effect of physician-based cognitive behavioural therapy among pregnant women with depressive symptomatology: a pilot quasi-experimental trial.  Early Interv Psychiatry. 2014;8(4):348-357.PubMedGoogle ScholarCrossref
22.
O’Mahen  H, Himle  JA, Fedock  G, Henshaw  E, Flynn  H.  A pilot randomized controlled trial of cognitive behavioral therapy for perinatal depression adapted for women with low incomes.  Depress Anxiety. 2013;30(7):679-687.PubMedGoogle ScholarCrossref
23.
Appleby  L, Warner  R, Whitton  A, Faragher  B.  A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression.  BMJ. 1997;314(7085):932-936.PubMedGoogle ScholarCrossref
24.
Rost  K, Nutting  P, Smith  J, Werner  J, Duan  N.  Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention: Quality Enhancement by Strategic Teaming.  J Gen Intern Med. 2001;16(3):143-149.PubMedGoogle ScholarCrossref
25.
O’Connor  EA, Whitlock  EP, Gaynes  BN, Beil  TL.  Screening for Depression in Adults and Older Adults in Primary Care: An Updated Systematic Review: Evidence Synthesis No. 75 [AHRQ Publication No. 10-05143-EF-1]. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
26.
Stone  M, Jones  ML. Clinical review: relationship between antidepressant drugs and suicidality in adults. In: Laughren TP. Memorandum: Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). Center for Drug Evaluation and Research, US Food and Drug Administration. http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf. Accessed July 14, 2015.
27.
Dalton  SO, Sørensen  HT, Johansen  C.  SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?  CNS Drugs. 2006;20(2):143-151.PubMedGoogle ScholarCrossref
28.
McDonagh  MS, Matthews  A, Phillipi  C,  et al.  Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis.  Obstet Gynecol. 2014;124(3):526-534.PubMedGoogle ScholarCrossref
29.
Clinical preventive service recommendation: depression. American Academy of Family Physicians. http://www.aafp.org/patient-care/clinical-recommendations/all/depression.html. Accessed July 14, 2015.
30.
Earls  MF; Committee on Psychosocial Aspects of Child and Family Health American Academy of Pediatrics.  Incorporating recognition and management of perinatal and postpartum depression into pediatric practice.  Pediatrics. 2010;126(5):1032-1039.PubMedGoogle ScholarCrossref
31.
Nimalasuriya  K, Compton  MT, Guillory  VJ; Prevention Practice Committee of the American College of Preventive Medicine.  Screening adults for depression in primary care: a position statement of the American College of Preventive Medicine.  J Fam Pract. 2009;58(10):535-538.PubMedGoogle Scholar
32.
Committee on Obstetric Practice.  The American College of Obstetricians and Gynecologists Committee Opinion No. 630: screening for perinatal depression.  Obstet Gynecol. 2015;125(5):1268-1271.PubMedGoogle ScholarCrossref
33.
Joffres  M, Jaramillo  A, Dickinson  J,  et al; Canadian Task Force on Preventive Health Care.  Recommendations on screening for depression in adults.  CMAJ. 2013;185(9):775-782.PubMedGoogle ScholarCrossref
34.
Mitchell  J, Trangle  M, Degnan  B,  et al.  Adult Depression in Primary Care. Bloomington, MN: Institute for Clinical Systems Improvement; 2013.
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    JAMA Editors Invite Your Comments
    JAMA Editors | JAMA and AMA
    JAMA is delighted to be able to publish US Preventive Services Task Force reports, beginning with this Screening for Depression statement in this issue. We welcome your responses to the recommendation.
    CONFLICT OF INTEREST: Employed by JAMA and the AMA.
    Special Communication
    USPSTF Recommendation Statement
    January 26, 2016

    Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement

    Albert L. Siu, MD, MSPH1,2; and the US Preventive Services Task Force (USPSTF)
    Author Affiliations
    • 1Mount Sinai School of Medicine, New York
    • 2James J. Peters Veterans Affairs Medical Center, Bronx, New York
    JAMA. 2016;315(4):380-387. doi:10.1001/jama.2015.18392
    Abstract

    Description  Update of the 2009 US Preventive Services Task Force (USPSTF) recommendation on screening for depression in adults.

    Methods  The USPSTF reviewed the evidence on the benefits and harms of screening for depression in adult populations, including older adults and pregnant and postpartum women; the accuracy of depression screening instruments; and the benefits and harms of depression treatment in these populations.

    Population  This recommendation applies to adults 18 years and older.

    Recommendation  The USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up. (B recommendation)

    ×